U.S. Markets closed
  • S&P Futures

    4,553.50
    -22.25 (-0.49%)
     
  • Dow Futures

    34,495.00
    -127.00 (-0.37%)
     
  • Nasdaq Futures

    15,895.25
    -93.25 (-0.58%)
     
  • Russell 2000 Futures

    2,183.70
    -21.50 (-0.97%)
     
  • Crude Oil

    66.90
    +0.40 (+0.60%)
     
  • Gold

    1,771.50
    +8.80 (+0.50%)
     
  • Silver

    22.34
    +0.03 (+0.13%)
     
  • EUR/USD

    1.1301
    -0.0005 (-0.0452%)
     
  • 10-Yr Bond

    1.4480
    +0.0140 (+0.98%)
     
  • Vix

    27.95
    -3.17 (-10.19%)
     
  • GBP/USD

    1.3286
    -0.0016 (-0.1222%)
     
  • USD/JPY

    113.1400
    -0.0690 (-0.0609%)
     
  • BTC-USD

    56,258.17
    -787.86 (-1.38%)
     
  • CMC Crypto 200

    1,429.05
    -9.84 (-0.68%)
     
  • FTSE 100

    7,129.21
    -39.47 (-0.55%)
     
  • Nikkei 225

    27,688.21
    -65.16 (-0.23%)
     

Catalent, Inc. to Present at the UBS Global Healthcare Virtual Conference

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced that members of its executive leadership team will virtually present at the UBS Global Healthcare Virtual Conference at 11:00 a.m. ET on May 26, 2021.

A live webcast of the presentation will be accessible at http://investor.catalent.com and will be available for replay following the event.

About Catalent, Inc.

Catalent, Inc. (NYSE: CTLT), an S&P 500® Company, is the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. With over 85 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable global clinical and commercial product supply. Catalent employs over 14,000 people, including over 2,400 scientists and technicians, at more than 40 facilities across four continents, and in fiscal year 2020 generated over $3 billion in annual revenue. Catalent is headquartered in Somerset, New Jersey. For more information, visit www.catalent.com.

More products. Better treatments. Reliably supplied.™

View source version on businesswire.com: https://www.businesswire.com/news/home/20210521005027/en/

Contacts

Investor Contact:
Paul Surdez, Catalent, Inc.
(732) 537-6325
investors@catalent.com